Article info
PDFShort report
Neuromuscular disease
B-cell-activating factor in rituximab-treated patients with anti-MAG polyneuropathy
- Correspondence to Dr Diego Franciotta, Laboratory of Neuroimmunology, IRCCS, Neurological Institute ‘C. Mondino,’ via Mondino 2, 27100 Pavia, Italy; diego.franciotta{at}mondino.it
Citation
B-cell-activating factor in rituximab-treated patients with anti-MAG polyneuropathy
Publication history
- Received June 25, 2010
- Revised September 2, 2010
- Accepted October 13, 2010
- First published December 16, 2010.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.